Effect of intratympanic gentamicin on hearing and tinnitus in Meniere's disease

American Journal of Otology

Volumn 20, Issue 3, 1999, Pages 350-356

  Eklund, Susanna ^a   Pyykkö, Ilmari ^b   Aalto, Heikki ^a   Ishizaki, Hisayoshi ^b   Vasama, Juha Pekka ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aminoglycosides; Hearing loss; Meniere's disease; Risk factors; Tinnitus

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; DRUG EFFECT; FACTORIAL ANALYSIS; FEMALE; HEARING; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; TINNITUS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; AUDIOMETRY, PURE-TONE; DEAFNESS; DECOMPRESSION, SURGICAL; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TINNITUS; VESTIBULAR NERVE;

EID: 0033491117     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kemink JL, Telian SA, Graham MD, Joynt L. Transmastoid labyrinthectomy: reliable surgical management of vertigo. Otolaryngol Head Neck Surg 1989;101:5-10.
2. Levine SC, Glasscock ME, McKennan KX. Long term results after labyrinthectomy. Laryngoscope 1990;100:125-7.
3. Goycoolea MW, Ruah CB, Lavinsky L, Morales-Garcia C. Overall view and rationale for surgical alternatives for incapacitating vertigo. Otolaryngol Clin North Am 1994;27:283-300.
4. Nguyen CD, Brackman DE, Crane RT, Linthicum FC, Hitzelberger WE. Retrolabyrinthine vestibular nerve section: evaluation of technical modification in 143 cases. Am J Otol 1992;13:328-32.
5. McElveen JT, Shelton C, Hitzelberger WE. Retrolabyrinthine vestibular neurectomy: a reevaluation. Laryngoscope 1988;98:502-6.
6. Fowler EP. Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol 1948;52:239-301.
7. Hamberger CA, Hyden H, Koch H. Streptomycin bei der Menierischen Krankheit. Arch Ohren Nasen Kehlkopfheilkd 1949;155:667-82.
8. Langman A, Kemink JL, Graham MD. Titration streptomycin therapy for bilateral Meniere's disease. Follow-up report. Ann Otol Rhinol Laryngol 1990;100:125-7.
9. Lindeman HH. Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics. Acta Otolaryngol (Stockh) 1969;67:177-89.
10. Kimura RS, Lee KS, Nye CL, Trehey JA. Effects of systemic and lateral semicircular canal administration of aminoglycosides on normal and hydropic inner ears. Acta Otolaryngol (Stockh) 1991;111:1021-30.
11. Shea JJ. Streptomycin perfusion of the inner ear. Am J Otol 1989;10:150-5.
12. Silverstein H. Streptomycin treatment for Meniere's disease. Ann Otol Rhinol Laryngol 1984;93 (Suppl 112):44-8.
13. Singleton EF, Schuknecht HF. Streptomycin sulfate in the management of Meniere's disease. Otolaryngol Clin North Am 1968;1:531-9.
14. Lange G. Die intratympanale Behandlung des Morbus Meniere mit ototoxichen Antibiotica. Laryngorhinootologie 1977;56:409-14.
15. Beck C, Schmidt CL. 10 years of experience with intratympanally applied streptomycin (gentamicin) in therapy of morbus Meniere. Arch Otorhinolaryngol 1978;221:149-52.
16. Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992;13:18-22.
17. Möller C, Ödqvist LM, Thell J, Larsby B, Hyden D. Vestibular and audiologic function in gentamicin treated Meniere's disease. Am J Otol 1988;9:383-91.
18. Sala T. Transtympanic administration of aminoglycosides in patients with Meniere's disease. Arch Otorhinolaryngol 1988;245:293-6.
19. Laitakari K. Intratympanic gentamicin in severe Meniere's disease. Clin Otolaryngol 1990;15:545-8.
20. Ödqvist LM, Bergholtz LM, Lundgre A. Topical gentamicin treatment for disabling Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1984;412:74-6.
21. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Acta Otolaryngol (Stockh) 1991;111:671-6.
22. Stahle J. Medical treatment of fluctuating hearing loss in Meniere's disease. Am J Otol 1984;5:529-33.
23. Pulec JL. Labyrinthectomy: indications, techniques and results. Laryngoscope 1974;84:1552-73.
24. Glasscock ME III, Miller GW, Drake FD, Kanok MM. Surgical management of Meniere's disease with the endolymphatic subarachnoidal shunt: a five-year study. Laryngoscope 1977;87:1668-85.
25. Moffat DA. Endolymphatic sac surgery: analysis of 100 operations. Clin Otolaryngol 1994;19:261-6.
26. Thomsen J, Bretlau P, Tos M, Johnsen J. Placebo effect in surgery for Meniere's disease. Arch Otolaryngol 1981;107:271-7.
27. Committee on Hearing and Equilibrium. Meniere's disease: criteria for diagnosis and evaluation of therapy for reporting. AAO-HNS Bulletin 1985;4:6-7.
28. Kaasinen S, Pyykkö I, Ishizaki H, Aalto H. Intratympanic gentamicin in Meniere's disease. Acta Otolaryngol (Stockh) 1998;118:294-8.
29. Kuk FK, Tyler RS, Russell D, Jordan H. The psychometric properties of a tinnitus handicap questionnaire. Ear Hear 1990;11:434-45.
30. Pyykkö I, Ishizaki H, Kaasinen S, Aalto H. Intratympanic gentamicin in bilateral Meniere's disease. Otolaryngol Head Neck Surg 1994;110:162-7.
31. Ramsay H. Endolymphatic Sac Surgery for Meniere's Disease. Helsinki: Ylipistopaino; 1987:80. Thesis.
32. Wersäll J, Björkroth F, Flock A, Lundquist PG. Experiments on ototoxic effects of antibiotics. Adv Otorhinolaryngol 1973;20:14-41.
33. Duvall III AJ, Robinson KS, Feist SJ. Cochlear permeability of neomycin and gentamicin: an immunohistochemical study. Arch Otorhinolaryngol 1991;248:319-25.
34. Bagger-Sjöbäck D, Bergenius J, Lundberg AM. Inner ear effects of topical gentamicin treatment in patients with Meniere's disease. Am J Otol 1990;11:406-10.
35. Orsulakova A, Stockhorst E, Schacht J. Effect of neomycin on phosphoinositide labeling and calcium binding in guinea-pig inner ear tissues in vivo and in vitro. J Neurochem 1976;26:285-90.
36. Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and nonsyndromic deafness. Nat Genet 1993;4:289-94.
37. House WF. Subarachnoidal shunt for drainage of hydrops. Laryngoscope 1965;75:1547-51.
38. Silverstein H. The effect of endolymphatic subarachnoid shunt operation on vestibular function. Laryngoscope 1978;88:1603-11.
39. Brummet RE, Fox KE, Brown RT, Himes DL. Comparative ototoxic liability of neomycin and gentamicin. Arch Otolaryngol Head Neck Surg 1978;104:579-84.
40. Aran JM, Dulon D, Hiel H, Erre JP. Aurousseau C. L'ototoxicite d'aminosides: resultats recents sur la captation et la clairance de la gentamicine par les cellules sensorielles du limacon osseux. Rev Laryngol Otol Rhinol 1993;114:125-8.
41. Yates GK, Johnstone BM, Patuzzi RB, Robertson D. Mechanical processing in the mammalian cochlea. Trends Neurosci 1992;15:57-61.
42. Kentala E. Characteristics of six otologic diseases involving vertigo. Am J Otol 1996;17:883-92.
43. Vernon J. Tinnitus: causes, evaluation and treatment. Otolaryngology Vol. 1 (Eng. ed.) 1993;53:1-25.
44. Silverstein H. The effect of endolymphatic subarachnoid shunt operation on vestibular function. Laryngoscope 1978;88:1603-11.
45. Möller AR. The pathophysiology of tinnitus. Ann Otol Rhinol Laryngol 1984;93:39-44.
46. Fee WE, Vierra V, Lathrop GR. Clinical evaluation of aminoglycoside ototoxicity: tobramycin versus gentamicin: a preliminary report. J Antimicrob Chemother Suppl A 1978;31.
47. Goebel G, Hiller W. Tinnitus-Fragebogen (TF). HNO 1944;42: 155-72.